GLP1R and type 2 diabetes mellitus: Other FDA approved medications for the treatment of type 2 diabetes, among which biguanides, alpha-glucosidase inhibitors (α-GIs), incretin-based drugs, GLP-1 receptor agonists and DPP-4 inhibitors also affect the gut microbiota (56).